Stock Code: 301393 Stock Abbreviation: Highfine Biotech
Suzhou Highfine Biotech Co., Ltd.
2026 Restricted Stock Incentive Plan (Draft) Summary
June 2026
Statement
The Company and all members of the Board of Directors guarantee that the contents of this announcement do not contain any false records, misleading statements, or major omissions, and assume legal responsibility for the authenticity, accuracy, and completeness of its contents.
All incentive recipients of the Company undertake that if the Company's information disclosure documents contain false records, misleading statements, or major omissions, resulting in non-compliance with the conditions for granting or vesting of equity, the incentive recipients shall return all benefits obtained from this incentive plan to the Company after the relevant information disclosure documents are confirmed to contain false records, misleading statements, or major omissions.
Special Notice
-
This incentive plan is formulated in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for Equity Incentives of Listed Companies, the Rules Governing the Listing of Stocks on the ChiNext Market of the Shenzhen Stock Exchange, the Guidelines No. 1 for Self-Regulation of Listed Companies on the ChiNext Market—Business Handling, and other relevant laws, regulations, and normative documents, as well as the Articles of Association of Suzhou Highfine Biotech Co., Ltd.
-
The incentive instrument adopted in this incentive plan is restricted stock (Type II restricted stock). The source of the stock is the Company's A-share common stock repurchased from the secondary market and/or issued directly to the incentive recipients by Suzhou Highfine Biotech Co., Ltd. (hereinafter referred to as the "Company").
Incentive recipients who meet the grant conditions of this incentive plan will, upon meeting the corresponding vesting conditions, obtain the Company's repurchased and/or directly issued A-share common stock at the grant price, and such shares will be registered with China Securities Depository and Clearing Corporation. Before vesting, the restricted stock granted to the incentive recipients does not carry shareholder rights, and such restricted stock may not be transferred, used for guarantees, or used to repay debts.
- The total amount of restricted stock intended to be granted to the incentive recipients under this incentive plan is 1.5107 million shares, accounting for 1.40% of the Company's total share capital of 108.00 million shares at the time of the announcement of the draft incentive plan. Among them, 1.2086 million shares are granted for the first time, accounting for 1.12% of the Company's total share capital of 108.00 million shares at the time of the announcement of the draft incentive plan, and the first grant portion accounts for 80.00% of the total equity granted this time; 0.3021 million shares are reserved, accounting for 0.28% of the Company's total share capital of 108.00 million shares at the time of the announcement of the draft incentive plan, and the reserved portion accounts for 20.00% of the total equity granted this time.
The total number of underlying shares involved in all of the Company's equity incentive plans within the validity period does not exceed 20% of the Company's total share capital. The total number of the Company's shares granted to any one incentive recipient through all equity incentive plans within the validity period does not exceed 1% of the Company's total share capital at the time the incentive plan is submitted to the general meeting of shareholders for deliberation.
- The grant price of the restricted stock for the first grant under this incentive plan is 27.10 yuan/share. The grant price for the reserved restricted stock is the same as the grant price for the first grant of restricted stock.